Early Integrated Palliative Care in Patients With Advanced Cancer
Frühe integrierte Palliativversorgung bei Patient:innen mit fortgeschrittenem Krebs
JAMA Network Open · 08.08.2024 · 7 (8) · e2426304
DOI: 10.1001/jamanetworkopen.2024.26304 ↗Auf einen Blick
In dieser RCT verbesserte frühe integrierte Palliativversorgung die Lebensqualität nach 18 Wochen. Bei 10 oder mehr Sitzungen war in der Interventionsgruppe die 2-Jahres-Überlebenswahrscheinlichkeit höher.
Fragestellung
Verbessert umfassende frühe palliativmedizinische Versorgung bei Patient:innen mit fortgeschrittenem Krebs die Lebensqualität, Belastung, Überleben und Bewältigungsfähigkeit?
Methode
Nicht verblindete randomisierte klinische Studie an 12 Krankenhäusern in Südkorea; 1:1-Randomisierung zu üblicher onkologischer Supportivversorgung oder EPC plus üblicher Versorgung; Analyse nach Intention-to-treat.
Ergebnisse
144 Patient:innen; 73 Intervention, 71 Kontrolle. Lebensqualität: Unterschied nach 18 Wochen 11,00 Punkte (95 %-KI 0,78–21,22; P = .04; Effektgröße 0,42), nach 12 und 24 Wochen kein signifikanter Unterschied. Coping: 20,51 Punkte (95 %-KI 12,41–28,61; P < .001; Effektgröße 0,93).
Schlussfolgerung der Autor:innen
Die RCT zeigte eine Verbesserung der Lebensqualität nach 18 Wochen, jedoch keine signifikanten Effekte nach 12 und 24 Wochen. Mehr Sitzungen waren mit höherer 2-Jahres-Überlebenswahrscheinlichkeit verbunden.
Kernaussagen
- Lebensqualität verbesserte sich signifikant nach 18 Wochen
- Coping-Skills verbesserten sich über 24 Wochen
- 10 oder mehr EPC-Sitzungen waren mit höherer 2-Jahres-Überlebenswahrscheinlichkeit assoziiert
Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.
Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift JAMA Network Open, online erschienen am 08.08.2024. Verfasst von EunKyo Kang und 16 weiteren Autor:innen. Beteiligte Einrichtung: National Cancer Control Institute, National Cancer Center, Goyang, Republic of Korea. Hauptthemen laut MEDLINE: Palliative Care, Quality of Life, Neoplasms. Die Arbeit wurde bisher 63-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Themen: Palliativpflege
Abstract (Originalsprache)
Importance Limited data suggest that early palliative care (EPC) improves quality of life (QOL) and survival in patients with advanced cancer.
Objective
To evaluate whether comprehensive EPC improves QOL; relieves mental, social, and existential burdens; increases survival rates; and helps patients develop coping skills. Design, Setting, and Participants This nonblinded randomized clinical trial (RCT) recruited patients from 12 hospitals in South Korea from September 2017 to October 2018. Patients aged 20 years or older with advanced cancer who were not terminally ill but for whom standard chemotherapy has not been effective were eligible. Participants were randomized 1:1 to the control (receiving usual supportive oncological care) or intervention (receiving EPC with usual oncological care) group. Intention-to-treat data analysis was conducted between September and December 2022.
Interventions
The intervention group received EPC through a structured program of self-study education materials, telephone coaching, and regular assessments by an integrated palliative care team. Main Outcomes and Measures The primary outcome was the change in overall QOL score (assessed with the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Core 15 Palliative Care) from baseline to 24 weeks after enrollment, with evaluations also conducted at 12 and 18 weeks. Secondary outcomes were social and existential burdens (assessed with the McGill Quality of Life Questionnaire) as well as crisis-overcoming capacity and 2-year survival.
Results
A total of 144 patients (83 males [57.6%]; mean [SD] age, 60.7 (7.2) years) were enrolled, of whom 73 were randomized to the intervention group and 71 to the control group. The intervention group demonstrated significantly greater changes in scores in overall health status or QOL from baseline, especially at 18 weeks (11.00 [95% CI, 0.78-21.22] points; P = .04; effect size = 0.42). However, at 12 and 24 weeks, there were no significant differences observed. Compared with the control group, the intervention group also showed significant improvement in self-management or coping skills over 24 weeks (20.51 [95% CI, 12.41-28.61] points; P < .001; effect size = 0.93). While the overall survival rate was higher in the intervention vs control group, the difference was not significant. In the intervention group, however, those who received 10 or more EPC interventions (eg, telephone coaching sessions and care team meetings) showed a significantly increased probability of 2-year survival (53.6%; P < .001). Conclusions and Relevance This RCT demonstrated that EPC enhanced QOL at 18 weeks; however, no significant improvements were observed at 12 and 24 weeks. An increased number of interventions sessions was associated with increased 2-year survival rates in the intervention group. Trial Registration ClinicalTrials.gov Identifier: NCT03181854
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- National Cancer Control Institute, National Cancer Center, Goyang, Republic of Korea.
- Department of Family Medicine, National Cancer Center, Goyang, Republic of Korea.
- Department of Internal Medicine, Gyeongsang National University, Jinju, Republic of Korea.
- Department of Hematology and Oncology, Ulsan University Hospital, Ulsan University College of Medicine, Ulsan, Republic of Korea.
- Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Republic of Korea.
- Department of Oncology, Asan Medical Center, Ulsan University College of Medicine, Seoul, Republic of Korea.
Zitieren
APA
Kang, E., Kang, J. H., Koh, S. J., Kim, Y. J., Seo, S., Kim, J. H., Cheon, J., Kang, E. J., Song, E. K., Nam, E. M., Oh, H. S., Choi, H. J., Kwon, J. H., Bae, W. K., Lee, J. E., Jung, K. H., & Yun, Y. H. (2024). Early Integrated Palliative Care in Patients With Advanced Cancer. JAMA Network Open, 7(8), e2426304. https://doi.org/10.1001/jamanetworkopen.2024.26304
Vancouver
Kang E, Kang JH, Koh SJ, Kim YJ, Seo S, Kim JH, et al. Early Integrated Palliative Care in Patients With Advanced Cancer. JAMA Network Open. 2024;7(8):e2426304. doi:10.1001/jamanetworkopen.2024.26304
BibTeX
@article{Kang2024,
author = {Kang, EunKyo and Kang, Jung Hun and Koh, Su-Jin and Kim, Yu Jung and Seo, Seyoung and Kim, Jung Hoon and Cheon, Jaekyung and Kang, Eun Joo and Song, Eun-Kee and Nam, Eun Mi and Oh, Ho-Suk and Choi, Hye Jin and Kwon, Jung Hye and Bae, Woo Kyun and Lee, Jeong Eun and Jung, Kyung Hae and Yun, Young Ho},
title = {Early Integrated Palliative Care in Patients With Advanced Cancer},
journal = {JAMA Network Open},
year = {2024},
volume = {7},
number = {8},
pages = {e2426304},
doi = {10.1001/jamanetworkopen.2024.26304}
}
EUVIMED